Subsequent catabolic effects and the impact on energy balance in terms of orexigenic signaling (e.g., via neuropeptide Y, NPY) further contribute to the maintenance of obesity and its comorbidities (Strack et al., 1995; Chrousos, 2009). This evidence concerns the gene NPY and obesity due to melanocortin 4 receptor deficiency.